30 reports

  • PRESENTS PRODUCT PROFILES FOR ANTI-EPILEPTICS THAT ARE USED TO TREAT MIGRAINE.
  • 5.2 RISK FACTORS AND COMORBIDITIES

ONE STUDY FOUND AN ASSOCIATION BETWEEN MIGRAINE AND BIPOLAR DISORDER (OR = ##. ##, ##% CI = ##. ##-##. ##).

  • Pain Relief
  • Allergan plc
  • Amgen Inc.
  • Eli Lilly & Co.
  • Pfizer Inc.

Zyprexa is used for the treatment of schizophrenia, acute mixed or manic episodes associated with bipolar I disorder and bipolar maintenance.

  • Addiction Disorder
  • Pain Relief
  • AstraZeneca PLC
  • Lilly Endowment Inc.
  • Pfizer Inc.
  • Residential Substance Abuse and Mental Health Facilities Market Characteristics

Pyschiatric Hospitals specialize in the treatment of serious mental disorders such as clinical depression, schizophrenia, and bipolar disorder.

  • Addiction Disorder
  • Specialty Hospital
  • World
  • Acadia Healthcare Company, Inc.
  • Universal Health Services, Inc.
  • EXECUTIVE SUMMARY
  • PRODUCTS AND SERVICES CONTINUED

The most common services provided are the treatment of schizophrenic and psychotic disorders, mood disorders such as depression, mania and bipolar disorder, anxiety disorders and personality disorders.

  • Addiction Disorder
  • Mental Health
  • Canada
  • Demand
  • Forecast
  • presents the total prevalent cases of migraine in the 7MM in 2016 and 2026.
  • 2.1 RELATED REPORTS

One study found an association between migraine and bipolar disorder (OR = ##. ##, ##% CI = ##. ##-##. ##).

  • Pain Relief
  • Japan
  • United States
  • World
  • Forecast
  • Products and services segmentation (2019)
  • Products & Markets

The vast majority of mood disorders are categorized as either depressive disorders or bipolar disorders.

  • Addiction Disorder
  • Mental Health
  • Canada
  • Demand
  • Forecast
  • PRODUCTS & SERVICES CONTINUED

Mood disorders include depressive disorder, dysthymic disorder and bipolar disorder; the NIMH estimates that ##. ##% of Americans over the age of ## suffer from these types of mental illnesses.

  • Addiction Disorder
  • Health Care Provider
  • Mental Health
  • United States
  • Forecast
  • Products & Markets

In addition, individuals with a bipolar disorder (i. e. manic depression) who maintain a regimen of lithium are much less likely to relapse than those not taking the medication.

  • Addiction Disorder
  • Ambulatory Care
  • Mental Health
  • United States
  • Demand

Methylphenidate Carbamazepine (CBZ) is an anticonvulsant and moodstabilizing drug used primarily in the treatment of epilepsy and bipolar disorder, as well as trigeminal neuralgia.

  • Pain Relief
  • China
  • Demand
  • Trade
  • Roche Group

Depakine is used in migraine along with a range of conditions from other therapy areas, including epilepsy and bipolar disorder.

  • Addiction Disorder
  • Pain Relief
  • Market Size
  • Allergan plc
  • Amgen Inc.

IT IS USED FOR THE MANAGEMENT OF ANXIETY DISORDERS AND SHORT-TERM RELIEF OF THE SYMPTOMS OF ANXIETY, EXCLUDING MILD AND MODERATE DEGREES OF ANXIETY AND ANXIETY-RELATED DISORDERS.

  • Neurological Disorder
  • Pain Relief
  • World
  • Forecast
  • Antares Pharma, Inc.

People with family members suffering from schizophrenia and bipolar disorder have a greater disposition to these conditions, and as a result, hereditary mental health problems support sustained demand.

  • Addiction Disorder
  • Mental Health
  • United Kingdom
  • Demand
  • Forecast
  • Target
  • Clinical Trial profile. 315 Trial Title

Risperidone for Bipolar Disorder with Comorbid Substance Use Disorder Divalproex ER vs.

  • Addiction Disorder
  • Opioid
  • Pain Relief
  • World
  • Alkermes plc

THE COMPANY' S PRODUCT PIPELINE COMPRISES DUR-## INDICATED FOR TREATMENT OF ACUTE ORGAN INJURIES AND METABOLIC/ LIPID DISORDERS REMOXY, INDICATED FOR CHRONIC PAIN POSIMIR, INDICATED FOR POST-OPERATIVE PAIN ELADUR, INDICATED FOR POST HERPETIC NEURALGIA ORADUR, INDICATED FOR CHRONIC

  • Addiction Disorder
  • Pain Relief
  • Pharmaceutical
  • United States
  • Company

The company reported that the drug candidate can also be used for the treatment of schizophrenia, bipolar disorder social anxiety disorder, insomnia, Huntington s disease.

  • Addiction Disorder
  • Pain Relief
  • Pharmaceutical
  • United States
  • Product Initiative

Its products are indicated for the treatment of diseases such as Alzheimer' s disease, depression, Parkinson' s disease, schizophrenia, alcohol dependence, anxiety, bipolar I disorder, epilepsy and Huntington' s disease, among others.

  • Addiction Disorder
  • Chronic Disease
  • Pain Relief
  • United States
  • Tonix Pharmaceuticals Holding Corp.

The company reported that the drug candidate can also be used for the treatment of schizophrenia, bipolar disorder social anxiety disorder, insomnia, Huntington s disease.

  • Addiction Disorder
  • Pain Relief
  • United States
  • Product Initiative
  • MediciNova, Inc.
  • Clinical Trial profile. 216 Trial Title
  • Target

Risperidone for Bipolar Disorder with Comorbid Substance Use Disorder Divalproex ER vs.

  • Addiction Disorder
  • Drug Development
  • Pain Relief
  • United States
  • World

PROPORTION OF MUSCLE SPASM TO MUSCULOSKELETAL DISORDERS CLINICAL TRIALS, G## COUNTRIES (%), 2018* PROPORTION OF MUSCLE SPASM TO MUSCULOSKELETAL DISORDERS CLINICAL TRIALS, G## COUNTRIES (%), 2018* PROPORTION OF MUSCLE SPASM TO MUSCULOSKELETAL DISORDERS CLINICAL TRIALS, G## COU

  • Clinical Trial
  • Pain Relief
  • Therapy
  • World
  • Product Initiative
  • 5. All the trials included are unique trials.

Reddy' s Under Fed Conditions GDCT## NCT##, P-##/ ##-## Central Nervous System Absence Seizure, Bipolar Disorder (Manic Depression), Complex Partial Seizure, Epilepsy, Mania, Migraine Completed Phase I Interventional divalproex sodium DR Dr.

  • Clinical Trial
  • Hormone
  • Pain Relief
  • Pharmaceutical
  • World
  • Target
  • Clinical Trial profile. 74 Trial Title

Risperidone for Bipolar Disorder with Comorbid Substance Use Disorder Divalproex ER vs.

  • Addiction Disorder
  • Antiseptics
  • Pain Relief
  • World
  • Alkermes plc

The effective date is ## May 2007.

  • Cardiology
  • Healthcare
  • Pain Relief
  • Pharmaceutical
  • Valeant Pharmaceuticals International, Inc.

CLINICAL TRIALS BY PHASE IN E## COUNTRIES MENSTRUAL DISORDERS THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* MENSTRUAL DISORDERS THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* MENSTRUAL DISORDERS THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE

  • Clinical Trial
  • Hormone
  • Pain Relief
  • World
  • Bayer AG

The effective date is ## May 2007.

  • Cardiology
  • Healthcare
  • Pain Relief
  • Pharmaceutical
  • Valeant Pharmaceuticals International, Inc.

The company reported that the drug candidate can also be used for the treatment of schizophrenia, bipolar disorder social anxiety disorder, insomnia, Huntington s disease.

  • Addiction Disorder
  • Drug Development
  • Pain Relief
  • United States
  • MediciNova, Inc.
  • MIGRAINE - PIPELINE BY IMPEL NEUROPHARMA INC, H2 2018
  • MIGRAINE - PIPELINE BY ELI LILLY AND CO, H2 2018

Impel' s products are used for the treatment of pain, depression, bipolar disorder, Alzheimer' s disease, migraine and Parkinson' s disease, among others.

  • Pain Relief
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

The company reported that the drug candidate can also be used for the treatment of schizophrenia, bipolar disorder social anxiety disorder, insomnia, Huntington s disease.

  • Addiction Disorder
  • Pain Relief
  • United States
  • Product Initiative
  • MediciNova, Inc.

Vraylar is indicated for treatment of manic or mixed episodes of bipolar ## disorder and schizophrenia in adults.

  • Ophthalmology
  • Pain Relief
  • United States
  • M&A
  • Allergan plc
  • Clinical Trial profile. 725 Trial Title
  • Clinical Trial profile. 726 Trial Title

Reddy' s Under Fed Conditions GDCT## NCT##, P-##/ ##-## Central Nervous System Absence Seizure, Bipolar Disorder (Manic Depression), Complex Partial Seizure, Epilepsy, Mania, Migraine Completed Phase I Interventional divalproex sodium DR Dr.

  • Neurology
  • Pain Relief
  • Pharmaceutical
  • World
  • Product Initiative

SK Biopharmaceuticals Co., Ltd. is developing SKL-PSY for the treatment of depression and bipolar disorder.

  • Addiction Disorder
  • Biopharmaceutical
  • Dementia
  • Pain Relief
  • SK Biopharmaceuticals Co., Ltd.